MEDOF (Medios AG) EPS without NRI: $0.95 (TTM As of Mar. 2026)


MEDOF Medios AG MEDOF
88 GF Score
Price $50.00
GF Value $71.50
! 2 Warning Signs
View Full Analysis

What is Medios AG EPS without NRI?

Medios AG MEDOF 88 EPS without NRI is $0.95 as of Mar. 2026. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $71.50. The stock has 2 warning signs investors should review. Among 102 Medical Distribution companies, Medios AG ranks worse than 69.61% on this metric.

Medios AG's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.23. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.95.

During the past 12 months, Medios AG's average earnings per share (NRI) Growth Rate was 39.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -11.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 9.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Medios AG's EPS without NRI or its related term are showing as below:

MEDOF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -42.3   Med: 2.7   Max: 31.2
Current: -11.2

During the past 13 years, Medios AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 31.20% per year. The lowest was -42.30% per year. And the median was 2.70% per year.

MEDOF's 3-Year EPS without NRI Growth Rate is ranked worse than
69.61% of 102 companies
in the Medical Distribution industry
Industry Median: 2.45 vs MEDOF: -11.20

Medios AG's EPS (Diluted) for the three months ended in Mar. 2026 was $0.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.65.

Medios AG's EPS (Basic) for the three months ended in Mar. 2026 was $0.23. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.65.


Medios AG  (OTCPK:MEDOF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medios AG EPS without NRI Related Terms


Medios AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for Medios AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medios AG EPS without NRI Chart

Medios AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.79 0.86 0.52 0.61

Medios AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.29 0.65 -0.21 0.23

MEDOF vs MCK, CAH, COR: EPS without NRI Comparison

For the Medical Distribution subindustry, Medios AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medios AG PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medios AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Medios AG's PE Ratio without NRI falls into.


MEDOF
88GF Score
Medios AG MEDOF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medios AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.95 mean?
Medios AG (MEDOF) has a EPS without NRI of $0.95 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medios AG and its competitors. According to the industry distribution chart, Medios AG ranks #71 out of 102 companies in the Medical Distribution industry, placing it in the top 69.6%.
Is Medios AG's EPS without NRI too high?
Medios AG's current EPS without NRI is $0.95. The Medical Distribution industry median EPS without NRI is 2.45. Medios AG's value of $0.95 is 61.2% below this industry median. Based on the distribution chart, Medios AG ranks #71 out of 102 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's EPS without NRI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #71 out of 102 companies for EPS without NRI. This places Medios AG in the lower half of its industry. The industry median EPS without NRI is 2.45. Medios AG's value of $0.95 is 61.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.45, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current EPS without NRI of $0.95 is 61.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current EPS without NRI is $0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current EPS without NRI of $0.95. The stock's GF Value™ is $71.50, compared to a current price of $50.00 — trading 30.1% below its estimated fair value. The current EPS without NRI is $0.95 and 61.2% below the Medical Distribution industry median of 2.45. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Medios AG (MEDOF), the current EPS without NRI is $0.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medios AG (MEDOF) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.

Key valuation signals for MEDOF:

  • EPS without NRI: $0.95
  • GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
  • GF Score™: 88/100 with 2 warning signs
  • Industry Position: 61.2% below the Medical Distribution median (#71 of 102)

No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for MEDOF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.00
Price
$71.50
GF Value